Crossmark

Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia

Crossref DOI link: https://doi.org/10.1186/s12941-023-00595-x

Published Online: 2023-07-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zuluaga, Nathalia

Martínez, David

Hernández, Carolina

Ballesteros, Nathalia

Castañeda, Sergio

Ramírez, Juan David

Muñoz, Marina
Funding

Funding for this research was provided by:

Universidad del Rosario
License Information

Text and Data Mining valid from 2023-07-07

Version of Record valid from 2023-07-07
More Information

Article History

Received: 22 April 2022

Accepted: 29 May 2023

First Online: 7 July 2023

Declarations

:

: The study was approved by the Comité de Ética en Investigación de la Universidad del Rosario (CEI-UR) with the number DVO005 15 08-CV1400. By the health emergency under the law 9-1979, decrees 786-1990 and 2323-2006 the Colombian National Institute of Health (INS) is authorized to use biospecimens and associated epidemiological information without the written consent. The study follows the principles of the Declaration of Helsinki, and also all patient data was anonymized to minimize risk to participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below